• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国囊性纤维化患者中铜绿假单胞菌对六种常用抗菌药物的耐药性调查。

Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.

作者信息

Pitt T L, Sparrow M, Warner M, Stefanidou M

机构信息

Laboratory of HealthCare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK.

出版信息

Thorax. 2003 Sep;58(9):794-6. doi: 10.1136/thorax.58.9.794.

DOI:10.1136/thorax.58.9.794
PMID:12947141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1746803/
Abstract

BACKGROUND

Respiratory infection with Pseudomonas aeruginosa is very common in patients with cystic fibrosis (CF) but antimicrobial resistance rates of CF isolates across the UK are largely unknown.

METHODS

The susceptibility of 417 CF patient isolates of P aeruginosa from 17 hospitals to six commonly prescribed antibiotics were examined. Isolates were tested by an agar break point dilution method and E-tests according to British Society of Antimicrobial Chemotherapy guidelines. Genotyping of isolates was performed by XbaI DNA macrorestriction and pulsed field gel electrophoresis.

RESULTS

38% of isolates were susceptible to all of the agents tested; almost half were resistant to gentamicin compared with ceftazidime (39%), piperacillin (32%), ciprofloxacin (30%), tobramycin (10%), and colistin (3%). Approximately 40% were resistant to two or more compounds with ceftazidime in combination with gentamicin, piperacillin or ciprofloxacin being the most common cross resistances. Resistance rates were generally similar to those reported recently from the USA and Germany. A selection of resistant isolates proved to be predominantly genotypically distinct by XbaI DNA macrorestriction but six pairs from three centres had similar genotypes.

CONCLUSIONS

The level of resistance to front line antipseudomonal agents, with the exception of colistin, is disturbingly high. The prudent use of antimicrobial drugs and closer monitoring of accumulation of resistant strain populations should be actively considered.

摘要

背景

铜绿假单胞菌呼吸道感染在囊性纤维化(CF)患者中非常常见,但英国CF分离株的抗菌药物耐药率基本未知。

方法

检测了来自17家医院的417株CF患者的铜绿假单胞菌分离株对六种常用抗生素的敏感性。根据英国抗菌化疗协会指南,采用琼脂断点稀释法和E试验对分离株进行检测。通过XbaI DNA宏观限制性内切酶消化和脉冲场凝胶电泳对分离株进行基因分型。

结果

38%的分离株对所有测试药物敏感;与头孢他啶(39%)、哌拉西林(32%)、环丙沙星(30%)、妥布霉素(10%)和黏菌素(3%)相比,近一半的分离株对庆大霉素耐药。约40%的分离株对两种或更多种化合物耐药,头孢他啶与庆大霉素、哌拉西林或环丙沙星联合耐药最为常见。耐药率总体上与美国和德国最近报道的相似。通过XbaI DNA宏观限制性内切酶消化,一组耐药分离株在基因型上主要不同,但来自三个中心的六对分离株具有相似的基因型。

结论

除黏菌素外,一线抗假单胞菌药物的耐药水平高得令人不安。应积极考虑谨慎使用抗菌药物并密切监测耐药菌株群体的积累。

相似文献

1
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.英国囊性纤维化患者中铜绿假单胞菌对六种常用抗菌药物的耐药性调查。
Thorax. 2003 Sep;58(9):794-6. doi: 10.1136/thorax.58.9.794.
2
In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.雾化剂黏菌素和妥布霉素以及五种静脉用药对从德国西南部囊性纤维化患者中分离出的铜绿假单胞菌的体外活性。
J Antimicrob Chemother. 2002 Feb;49(2):403-6. doi: 10.1093/jac/49.2.403.
3
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.来自伊朗北部戈尔甘的铜绿假单胞菌临床分离株的抗菌耐药性、毒力因子和基因型。
Int Microbiol. 2022 Nov;25(4):709-721. doi: 10.1007/s10123-022-00256-7. Epub 2022 Jun 14.
4
Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.从囊性纤维化患者中分离出的铜绿假单胞菌对美罗培南和 13 种对照抗生素的敏感性。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01541-19.
5
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.依伐卡托是否会干扰常用抗生素对铜绿假单胞菌的抗菌活性?——一项体外研究的结果。
J Clin Pharm Ther. 2018 Dec;43(6):836-843. doi: 10.1111/jcpt.12722. Epub 2018 Jun 29.
6
High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.从捷克共和国囊性纤维化患者中分离出的铜绿假单胞菌菌株具有高度的基因型多样性。
Res Microbiol. 2007 May;158(4):324-9. doi: 10.1016/j.resmic.2007.02.003. Epub 2007 Mar 3.
7
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.β-内酰胺耐药铜绿假单胞菌在一家囊性纤维化诊所的传播。
Lancet. 1996 Sep 7;348(9028):639-42. doi: 10.1016/S0140-6736(96)05169-0.
8
Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.接受抗菌治疗的慢性囊性纤维化定植患者中分离出的铜绿假单胞菌对妥布霉素和黏菌素的耐药性
Scand J Infect Dis. 2010 Dec;42(11-12):885-9. doi: 10.3109/00365548.2010.509333. Epub 2010 Aug 25.
9
Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.按感染类型分层的美国医疗中心分离出的肠杆菌科细菌和铜绿假单胞菌的抗菌药敏性:国际最佳耐药监测网络(INFORM)监测项目2015 - 2016年的结果
Diagn Microbiol Infect Dis. 2018 Sep;92(1):69-74. doi: 10.1016/j.diagmicrobio.2018.04.012. Epub 2018 Apr 26.
10
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?囊性纤维化患者呼吸道假单胞菌感染的治疗:用什么药物及采用何种方式?
Drugs. 2000 Nov;60(5):1053-64. doi: 10.2165/00003495-200060050-00006.

引用本文的文献

1
The in vitro evaluation of synergistic effects of ciprofloxacin and berberine hydrochloride against Pseudomonas aeruginosa.环丙沙星与盐酸小檗碱对铜绿假单胞菌协同作用的体外评价
BMC Microbiol. 2025 Aug 7;25(1):487. doi: 10.1186/s12866-025-04223-w.
2
Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria.基于磷脂、胆固醇、黏菌素和壳聚糖的杂化纳米颗粒(HNPs)对多重耐药革兰氏阴性菌的研制、表征及抗菌评估
Pharmaceutics. 2025 Feb 1;17(2):182. doi: 10.3390/pharmaceutics17020182.
3
Aspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants of isolates within cystic fibrosis airway mucus.天冬氨酸被揭示为一种抗生物膜剂,也是针对囊性纤维化气道黏液中分离株的黏液样和小菌落变体的妥布霉素佐剂。
Biofilm. 2024 Dec 30;9:100252. doi: 10.1016/j.bioflm.2024.100252. eCollection 2025 Jun.
4
Prevalence of colistin resistance in clinical isolates of : a systematic review and meta-analysis.临床分离株中黏菌素耐药性的流行情况:一项系统评价和荟萃分析。
Front Microbiol. 2024 Oct 9;15:1477836. doi: 10.3389/fmicb.2024.1477836. eCollection 2024.
5
Scorpionfish BPI is highly active against multiple drug-resistant isolates from people with cystic fibrosis.蝎鱼 BPI 对来自囊性纤维化患者的多种耐药分离株具有高度活性。
Elife. 2023 Jul 18;12:e86369. doi: 10.7554/eLife.86369.
6
The role of nanotechnology-based approaches for clinical infectious diseases and public health.基于纳米技术的方法在临床传染病和公共卫生中的作用。
Front Bioeng Biotechnol. 2023 Apr 3;11:1146252. doi: 10.3389/fbioe.2023.1146252. eCollection 2023.
7
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary and Infections in Cystic Fibrosis.用于囊性纤维化慢性肺部感染的当前及新出现的吸入性抗生素
Antibiotics (Basel). 2023 Feb 28;12(3):484. doi: 10.3390/antibiotics12030484.
8
Parallel Evolution to Elucidate the Contributions of PA0625 and to Ciprofloxacin Sensitivity in .通过平行进化阐明PA0625对环丙沙星敏感性的贡献及在……中的作用
Microorganisms. 2022 Dec 21;11(1):13. doi: 10.3390/microorganisms11010013.
9
Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: Results from CARVIS-NET program.中国从血流感染中分离出的革兰氏阴性菌对多粘菌素B及其他对照抗菌药物的敏感性:CARVIS-NET项目的结果
Front Microbiol. 2022 Oct 6;13:1017488. doi: 10.3389/fmicb.2022.1017488. eCollection 2022.
10
Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.病原体在囊性纤维化肺中的适应与进化。
J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S23-S31. doi: 10.1093/jpids/piac073.

本文引用的文献

1
Two simple media for the demonstration of pyocyanin and fluorescin.两种用于展示绿脓菌素和荧光素的简单培养基。
J Lab Clin Med. 1954 Aug;44(2):301-7.
2
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?铜绿假单胞菌抗菌耐药的多种机制:是我们最可怕的噩梦?
Clin Infect Dis. 2002 Mar 1;34(5):634-40. doi: 10.1086/338782. Epub 2002 Jan 25.
3
In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.雾化剂黏菌素和妥布霉素以及五种静脉用药对从德国西南部囊性纤维化患者中分离出的铜绿假单胞菌的体外活性。
J Antimicrob Chemother. 2002 Feb;49(2):403-6. doi: 10.1093/jac/49.2.403.
4
Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.在长期被铜绿假单胞菌定植的成年囊性纤维化患者中发生铜绿假单胞菌可传播菌株的重叠感染。
Lancet. 2001 Aug 18;358(9281):558-60. doi: 10.1016/s0140-6736(01)05715-4.
5
Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.多重耐药铜绿假单胞菌菌株在一家成人囊性纤维化诊所中的传播。
Lancet. 2001 Aug 18;358(9281):557-8. doi: 10.1016/s0140-6736(01)05714-2.
6
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.确定最低抑菌浓度(MIC)断点及体外药敏试验结果的解读。
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:17-28. doi: 10.1093/jac/48.suppl_1.17.
7
Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test.铜绿假单胞菌的抗菌药敏性:英国一项调查结果及对英国抗菌化疗协会纸片药敏试验的评估
J Antimicrob Chemother. 2001 Jun;47(6):789-99. doi: 10.1093/jac/47.6.789.
8
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.囊性纤维化患者抗铜绿假单胞菌的抗生素治疗:欧洲共识
Eur Respir J. 2000 Oct;16(4):749-67. doi: 10.1034/j.1399-3003.2000.16d30.x.
9
Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?抗假单胞菌抗生素对囊性纤维化急性加重期真的有益吗?
Aust N Z J Med. 1999 Feb;29(1):15-21. doi: 10.1111/j.1445-5994.1999.tb01583.x.
10
Multiresistant non-fermentative gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study. Italian Group for Cystic Fibrosis microbiology.囊性纤维化患者中的多重耐药非发酵革兰氏阴性菌:一项意大利多中心研究的结果。意大利囊性纤维化微生物学小组
Eur J Epidemiol. 1999 Jan;15(1):85-8. doi: 10.1023/a:1007504524034.